Evidence map›Paper›PMID 27453576›Full record

ArticleAmerican journal of human genetics2016

BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription.

Cristina Dias, Sara B Estruch, Sarah A Graham, Jeremy McRae, Stephen J Sawiak, Jane A Hurst, Shelagh K Joss, Susan E Holder, Jenny E V Morton, Claire Turner and 14 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The genetic architecture of fibromyalgia across 2.5 million individuals.medRxiv : the preprint server for health sciences · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 15 institutions in 4 countries.

Cristina DiasWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Sara B EstruchLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, PO Box 310, 6500 AH Nijmegen, the Netherlands.
Sarah A GrahamLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, PO Box 310, 6500 AH Nijmegen, the Netherlands.
Jeremy McRaeWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Stephen J SawiakBehavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge CB2 3EB, UK; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge CB2 0QQ, UK.
Jane A HurstNorth East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.
Shelagh K JossWest of Scotland Regional Genetics Service, Level 2 Laboratory Medicine Building, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK.
Susan E HolderNorth West Thames Regional Genetics Service, London North West Healthcare NHS Trust, Watford Rd, Harrow HA1 3UJ, UK.
Jenny E V MortonWest Midlands Regional Genetics Service, Birmingham Women's NHS Foundation Trust, Birmingham Women's Hospital, Edgbaston, Birmingham B15 2TG, UK.
Claire TurnerPeninsula Clinical Genetics Service, Department of Clinical Genetics, Royal Devon and Exeter NHS Foundation Trust, Clinical Genetics Department, Royal Devon & Exeter Hospital (Heavitree), Gladstone Road, Exeter EX1 2ED, UK.
Julien ThevenonFédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, 21079 Dijon, France; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est, Centre Hospitalier Universitaire Dijon, 21079 Dijon, France.
Kelly MellulService de Génétique, Hôpital Necker-Enfants Malades, APHP, Institut Imagine, INSERM UMR1163, University Sorbonne-Paris-Cité, 75015 Paris, France.
Gabriela Sánchez-AndradeWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Ximena Ibarra-SoriaWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Pelagia DeriziotisLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, PO Box 310, 6500 AH Nijmegen, the Netherlands.
Rui F SantosChildren's Radiology Department, Royal Manchester Children's Hospital, Manchester M13 9WL, UK.
Song-Choon LeeWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK; Science Centre Singapore, 15 Science Centre Road, Singapore 609081, Singapore.
Laurence FaivreFédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, 21079 Dijon, France; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est, Centre Hospitalier Universitaire Dijon, 21079 Dijon, France.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Pentao LiuWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Mathew E HurlesWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
DDD Study
Simon E FisherLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, PO Box 310, 6500 AH Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, 6525 EN Nijmegen, the Netherlands. Electronic address: simon.fisher@mpi.nl.
Darren W LoganWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK. Electronic address: dl5@sanger.ac.uk.
Wellcome Sanger Institute · GBMax Planck Institute for Psycholinguistics · NLBirmingham Women's Hospital · GBCentre Hospitalier Universitaire Dijon Bourgogne · FRFédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine · FRGreat Ormond Street Hospital · GBLondon North West Healthcare NHS Trust · GBQueen Elizabeth University Hospital · GBRadboud University Medical Center · NLRadboud University Nijmegen · NLRoyal Devon & Exeter NHS Foundation Trust · GBRoyal Manchester Children's Hospital · GBSingapore Science Park · SGUniversité Paris Cité · FRUniversity of Cambridge · GB

Funding

Department of HealthWellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

Intellectual disability (ID) is a common condition with considerable genetic heterogeneity. Next-generation sequencing of large cohorts has identified an increasing number of genes implicated in ID, but their roles in neurodevelopment remain largely unexplored. Here we report an ID syndrome caused by de novo heterozygous missense, nonsense, and frameshift mutations in BCL11A, encoding a transcription factor that is a putative member of the BAF swi/snf chromatin-remodeling complex. Using a comprehensive integrated approach to ID disease modeling, involving human cellular analyses coupled to mouse behavioral, neuroanatomical, and molecular phenotyping, we provide multiple lines of functional evidence for phenotypic effects. The etiological missense variants cluster in the amino-terminal region of human BCL11A, and we demonstrate that they all disrupt its localization, dimerization, and transcriptional regulatory activity, consistent with a loss of function. We show that Bcl11a haploinsufficiency in mice causes impaired cognition, abnormal social behavior, and microcephaly in accordance with the human phenotype. Furthermore, we identify shared aberrant transcriptional profiles in the cortex and hippocampus of these mouse models. Thus, our work implicates BCL11A haploinsufficiency in neurodevelopmental disorders and defines additional targets regulated by this gene, with broad relevance for our understanding of ID and related syndromes.

Indexed as

Transcription, GeneticAnimalsCarrier ProteinsCerebral CortexChromatin Assembly and DisassemblyCodon, NonsenseCognition DisordersFrameshift MutationHaploinsufficiencyHippocampusHumansIntellectual DisabilityMaleMiceMicrocephalyMutation, MissenseBCL11A protein, humanCarrier ProteinsCodon, NonsenseNuclear ProteinsRepressor ProteinsTranscription Factors

Identifiers

PMID27453576
PMCPMC4974071
OpenAlexW2480659285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.